Optic nerve glioma primary prevention: Difference between revisions
No edit summary |
Simrat Sarai (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Optic nerve glioma}} | {{Optic nerve glioma}} | ||
{{CMG}} | {{CMG}}{{AE}}{{Simrat}} | ||
==Overview== | ==Overview== | ||
Effective measures for the primary prevention of optic nerve glioma include regular eye exams in patients with neurofibromatosis type 1. | |||
==Primary Prevention== | ==Primary Prevention== | ||
Optic pathway glioma occurs in 15 percent of patients with neurofibromatosis 1. Regular eye exams may allow early diagnosis of these tumors before they cause symptoms. Clinical evaluation in patients with NF-1 appears to be more useful to detect complications than are screening investigations in asymptomatic patients.<ref name="pmid9207339">{{cite journal| author=Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE et al.| title=The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. | journal=JAMA | year= 1997 | volume= 278 | issue= 1 | pages= 51-7 | pmid=9207339 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9207339 }} </ref><ref name="pmid8915311">{{cite journal| author=Wolkenstein P, Frèche B, Zeller J, Revuz J| title=Usefulness of screening investigations in neurofibromatosis type 1. A study of 152 patients. | journal=Arch Dermatol | year= 1996 | volume= 132 | issue= 11 | pages= 1333-6 | pmid=8915311 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8915311 }} </ref> The optimal care for individuals with NF1 aims at the symptomatic treatment and early detection of complications as they occur. Genetic counseling may be advised for people with neurofibromatosis-1. | |||
==References== | ==References== | ||
Revision as of 21:44, 4 October 2015
|
Optic nerve glioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Optic nerve glioma primary prevention On the Web |
|
American Roentgen Ray Society Images of Optic nerve glioma primary prevention |
|
Risk calculators and risk factors for Optic nerve glioma primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]
Overview
Effective measures for the primary prevention of optic nerve glioma include regular eye exams in patients with neurofibromatosis type 1.
Primary Prevention
Optic pathway glioma occurs in 15 percent of patients with neurofibromatosis 1. Regular eye exams may allow early diagnosis of these tumors before they cause symptoms. Clinical evaluation in patients with NF-1 appears to be more useful to detect complications than are screening investigations in asymptomatic patients.[1][2] The optimal care for individuals with NF1 aims at the symptomatic treatment and early detection of complications as they occur. Genetic counseling may be advised for people with neurofibromatosis-1.
References
- ↑ Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE; et al. (1997). "The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2". JAMA. 278 (1): 51–7. PMID 9207339.
- ↑ Wolkenstein P, Frèche B, Zeller J, Revuz J (1996). "Usefulness of screening investigations in neurofibromatosis type 1. A study of 152 patients". Arch Dermatol. 132 (11): 1333–6. PMID 8915311.